Gene therapy for HIV.
Lever
A M
AM
University of Cambridge Department of Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK. amll1@mole.bio.cam.ac.uk
D000914:Antibodies, Viral / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000379:methods*; D015658:HIV Infections / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D016372:RNA, Antisense / Q000627:therapeutic use; D016337:RNA, Catalytic / Q000627:therapeutic use; D013873:Thionucleotides
D000914:Antibodies, Viral; D000998:Antiviral Agents; D016376:Oligonucleotides, Antisense; D016372:RNA, Antisense; D016337:RNA, Catalytic; D013873:Thionucleotides; D007372:Interferons